Evidence map›Paper›PMID 40860209›Full record

ArticleInternational journal of surgery protocols2025

Research protocol for the evaluation of TriNetra™ prostate: a circulating tumor cell-based diagnostic tool for prostate cancer.

Juan Gómez Rivas, Paula Mata Deniz, Arianna Pischetola, Moisés Rodríguez Socarrás, Vanesa Cuadros Rivera, Fernando Gómez Sancha, Isabel Galante, Lorena Fernández Montarroso, Francesco Esperto, Jesús Moreno Sierra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of surgery protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Juan Gómez RivasDepartment of Urology, Health Research Institute, Hospital Clínico San Carlos, Madrid, Spain.ORCID https://orcid.org/0000-0002-0556-3035
Paula Mata DenizDepartment of Urology, Health Research Institute, Hospital Clínico San Carlos, Madrid, Spain.
Arianna PischetolaFaculty of Medicine, University Campus Bio-Medico of Rome, Rome, Italy.ORCID https://orcid.org/0009-0009-8313-6619
Moisés Rodríguez SocarrásInstituto de Cirugía Urológica Avanzada(ICUA)- Clínica CEMTRO II, Madrid, Spain.
Vanesa Cuadros RiveraInstituto de Cirugía Urológica Avanzada(ICUA)- Clínica CEMTRO II, Madrid, Spain.
Fernando Gómez SanchaInstituto de Cirugía Urológica Avanzada(ICUA)- Clínica CEMTRO II, Madrid, Spain.
Isabel GalanteDepartment of Urology, Health Research Institute, Hospital Clínico San Carlos, Madrid, Spain.
Lorena Fernández MontarrosoDepartment of Urology, Health Research Institute, Hospital Clínico San Carlos, Madrid, Spain.ORCID https://orcid.org/0000-0002-9082-1608
Francesco EspertoFaculty of Medicine, University Campus Bio-Medico of Rome, Rome, Italy.ORCID https://orcid.org/0000-0002-0108-1864
Jesús Moreno SierraDepartment of Urology, Health Research Institute, Hospital Clínico San Carlos, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is one of the most prevalent malignancies among men, with early and accurate diagnosis is essential for optimizing clinical outcomes. The Trinetra-Prostate

Indexed as

circulating tumor cells (CTCs)liquid biopsynoninvasive diagnosticsprostate cancertriNetra™ prostate

Identifiers

PMID40860209
PMCPMC12373044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.